| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16130065 |
| PharmacoGx | BRD-K16130065 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VANGL1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | ZSCAN22 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | ZC3H7A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | ANKDD1A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | ARL13B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | SLAMF6 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | TMEM115 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | CHGB | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | TMEM19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | ZDHHC9 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
